Skip to content

Pharmacy

NPC shares new IRA-related research in AJMC

NPC shares new IRA-related research in AJMC

WASHINGTON – The Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program (DPNP) may lead to fewer subsequent indications and delay launches for small molecule drugs, according to new research from the National Pharmaceutical Council (NPC) published in the American Journal of Managed

Cigna sells Medicare business for $3.7 billion

Cigna sells Medicare business for $3.7 billion

The Cigna Group will sell its Medicare business to another insurer, Health Care Service Corp., for about $3.7 billion. Cigna said Wednesday the deal includes its Medicare Advantage insurance, a supplemental benefits business and Medicare prescription drug coverage.